임상 검사 서비스 시장 규모, 점유율, 동향 분석 보고서 : 검사 유형별, 서비스 프로바이더별, 용도별, 지역별, 부문별 예측(2026-2033년)

Clinical Laboratory Services Market Summary

The global clinical laboratory services market size was valued at USD 224.35 billion in 2025 and is expected to reach USD 308.24 billion by 2033, expanding at a CAGR of 4.28% from 2026 to 2033. The market is witnessing growth due to factors such as the increasing burden of chronic diseases and the growing demand for early diagnostic tests.

For instance, the rising incidence of diabetes and cardiovascular disease is driving the demand for frequent blood glucose and lipid profile screenings, while early cancer detection activities are rapidly expanding. According to the International Diabetes Federation 2024, diabetes affected 589 million adults aged 20 to 79 worldwide, accounting for one in every nine. Rapid advancements in data handling and sample preparation, such as the adoption of automated laboratory information management systems (LIMS) and high-throughput sample processing platforms, are projected to drive market expansion throughout the projection period.

Clinical lab services are widely used for various applications, primarily for detecting and quantifying different biological substances. Variations in biomolecular concentrations can indicate various abnormal metabolic activities, infections, infectious and non-infectious diseases, and inflammatory conditions. To ensure optimal clinical results and overall public health, it's vital to rapidly and accurately diagnose severe illnesses and administer appropriate treatment.

Automation in clinical settings has significantly improved the data management process in laboratories. Growing adoption of laboratory automation systems is expected to boost the market during the forecast period. Furthermore, database management tools, patient test records, and integrated workflow management systems have received significant consideration in the healthcare industry. This can be attributed mainly to companies that process nearly 100 to 150 billion samples per year. Hence, the improvement and implementation of informatics and automated data management solutions to perform seamless operations are anticipated to drive the market.

Global Clinical Laboratory Services Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical laboratory services market report on the basis of test type, service provider, application, and region:

• Test Type Outlook (Revenue, USD Million, 2021 - 2033)
• Genetic Testing
• Clinical Chemistry
  • Routine Chemistry Testing
  • Therapeutic Drug Monitoring Testing
  • Endocrinology Chemistry Testing
  • Specialized Chemistry Testing
  • Other Clinical Chemistry Testing
• Medical Microbiology Testing
  • Infectious Disease Testing
  • Transplant Diagnostic Testing
  • Other Microbiology Testing
• Hematology Testing
• Immunology Testing
• Cytology Testing
• Drug of Abuse Testing
• Other Esoteric Tests
• Service Provider Outlook (Revenue, USD Million, 2021 - 2033)
• Hospital-Based Laboratories
• Stand-Alone Laboratories
• Clinic-Based Laboratories
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Bioanalytical & Lab Chemistry Services
• Toxicology Testing Services
• Cell & Gene Therapy Related Services
• Preclinical & Clinical Trial Related Services
• Drug Discovery & Development Related Services
• Other Clinical Laboratory Services
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Colombia
  • Peru
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Clinical laboratory services market: Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Test Type Method
    • 1.1.1.2. Service Provider Segment
    • 1.1.1.3. Application Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective - 1
  • 1.4.2. Objective - 2
  • 1.4.3. Objective - 3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Clinical laboratory services market: Executive Summary

• 2.1. Market Snapshot
• 2.2. Test Type Snapshot
• 2.3. Service Provider Snapshot
• 2.4. Application Snapshot
• 2.5. Competitive Landscape Snapshot

Chapter 3. Clinical laboratory services market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers Analysis
  • 3.4.1. Technological advancements in the field of clinical testing
  • 3.4.2. Growing prevalence of target diseases coupled with rising demand for early disease diagnostic tests
  • 3.4.3. Introduction of novel solutions
  • 3.4.4. Outbreak of COIVD-19 pandemic
• 3.5. Market Restraint Analysis
  • 3.5.1. Presence of stringent regulatory framework
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis
• 3.8. Pipeline Analysis

Chapter 4. Clinical laboratory services market: Test Type Estimates & Trend Analysis

• 4.1. Clinical laboratory services market: Test Type Movement Analysis
• 4.2. Genetic testing
  • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.3. Clinical chemistry
  • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Routine chemistry testing
    • 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Therapeutic drug monitoring testing
    • 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.4. Endocrinology chemistry testing
    • 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.5. Specialized chemistry testing
    • 4.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.6. Other clinical chemistry testing
    • 4.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Medical microbiology & cytology
  • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Infectious disease testing
    • 4.4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Transplant diagnostic testing
    • 4.4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Other microbiology testing
    • 4.4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Hematology testing
  • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Immunology testing
  • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Cytology testing
  • 4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Drug of abuse testing
  • 4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Other esoteric tests
  • 4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Clinical laboratory services market: Service Provider Estimates & Trend Analysis

• 5.1. Clinical laboratory services market: Service Provider Movement Analysis
• 5.2. Hospital-based laboratories
  • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.3. Stand-alone laboratories
  • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Clinic-based laboratories
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Clinical laboratory services market: Application Estimates & Trend Analysis

• 6.1. Clinical laboratory services market: Service Provider Movement Analysis
• 6.2. Bioanalytical & lab chemistry services
  • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.3. Toxicology testing services
  • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Cell & gene therapy related services
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Preclinical & clinical trial related services
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Drug discovery & development related services
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Other clinical laboratory services
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Clinical laboratory services market: Regional Business Analysis

• 7.1. Regional Market Snapshot
• 7.2. North America
  • 7.2.1. North America Clinical laboratory services market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Competitive Scenario
    • 7.2.2.3. Regulatory Framework
    • 7.2.2.4. Reimbursement Scenario
    • 7.2.2.5. U.S. Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Competitive Scenario
    • 7.2.3.3. Regulatory Framework
    • 7.2.3.4. Reimbursement Scenario
    • 7.2.3.5. Canada Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Competitive Scenario
    • 7.2.4.3. Regulatory Framework
    • 7.2.4.4. Reimbursement Scenario
    • 7.2.4.5. Mexico Clinical laboratory services market, 2021 - 2033 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Framework
    • 7.3.2.4. Reimbursement Scenario
    • 7.3.2.5. UK Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Framework
    • 7.3.3.4. Reimbursement Scenario
    • 7.3.3.5. Germany Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.3.4. Spain
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Framework
    • 7.3.4.4. Reimbursement Scenario
    • 7.3.4.5. Spain Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.3.5. France
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Competitive Scenario
    • 7.3.5.3. Regulatory Framework
    • 7.3.5.4. Reimbursement Scenario
    • 7.3.5.5. France Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.3.6. Italy
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Competitive Scenario
    • 7.3.6.3. Regulatory Framework
    • 7.3.6.4. Reimbursement Scenario
    • 7.3.6.5. Italy Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1.
    • 7.3.7.2. Key Country Dynamics
    • 7.3.7.3. Competitive Scenario
    • 7.3.7.4. Regulatory Framework
    • 7.3.7.5. Reimbursement Scenario
    • 7.3.7.6. Denmark Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Competitive Scenario
    • 7.3.8.3. Regulatory Framework
    • 7.3.8.4. Reimbursement Scenario
    • 7.3.8.5. Sweden Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Competitive Scenario
    • 7.3.9.3. Regulatory Framework
    • 7.3.9.4. Reimbursement Scenario
    • 7.3.9.5. Norway Clinical laboratory services market, 2021 - 2033 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia-Pacific Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Reimbursement Scenario
    • 7.4.2.5. Japan Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Reimbursement Scenario
    • 7.4.3.5. China Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Reimbursement Scenario
    • 7.4.4.5. India Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Framework
    • 7.4.5.4. Reimbursement Scenario
    • 7.4.5.5. South Korea Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.4.6. Thailand
    • 7.4.6.1. Thailand Clinical laboratory services market, 2021 - 2033 (USD Million)
    • 7.4.6.2. Key Country Dynamics
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Reimbursement Scenario
    • 7.4.6.6. Thailand Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.4.7. Australia
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Framework
    • 7.4.7.4. Reimbursement Scenario
    • 7.4.7.5. Australia Clinical laboratory services market, 2021 - 2033 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. Brazil Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.5.3. Colombia
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. Colombia Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.5.4. Peru
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. Peru Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.5.5. Argentina
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Reimbursement Scenario
    • 7.5.5.5. Argentina Clinical laboratory services market, 2021 - 2033 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. South Africa Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Saudi Arabia Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement Scenario
    • 7.6.4.5. UAE Clinical laboratory services market, 2021 - 2033 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement Scenario
    • 7.6.5.5. Kuwait Clinical laboratory services market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Heat Map Analysis
• 8.4. Company Profiles
  • 8.4.1. Laboratory Corporation of America Holdings (LabCorp)
    • 8.4.1.1. Company Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. QIAGEN
    • 8.4.2.1. Company Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Eurofins Scientific
    • 8.4.3.1. Company Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Quest Diagnostics Incorporated
    • 8.4.4.1. Company Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. OPKO Health, Inc.
    • 8.4.5.1. Company Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. Siemens Healthineers AG
    • 8.4.6.1. Company Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. NeoGenomics Laboratories.
    • 8.4.7.1. Company Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Fresenius Medical Care.
    • 8.4.8.1. Company Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. ARUP Laboratories.
    • 8.4.9.1. Company Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Sonic Healthcare Limited
    • 8.4.10.1. Company Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Strategic Initiatives
  • 8.4.11. Charles River Laboratories.
    • 8.4.11.1. Company Overview
    • 8.4.11.2. Financial Performance
    • 8.4.11.3. Product Benchmarking
    • 8.4.11.4. Strategic Initiatives
  • 8.4.12. SYNLAB International
    • 8.4.12.1. Company Overview
    • 8.4.12.2. Financial Performance
    • 8.4.12.3. Product Benchmarking
    • 8.4.12.4. Strategic Initiatives
  • 8.4.13. Mayo Clinic Laboratories
    • 8.4.13.1. Company Overview
    • 8.4.13.2. Financial Performance
    • 8.4.13.3. Product Benchmarking
    • 8.4.13.4. Strategic Initiatives
  • 8.4.14. Unilabs
    • 8.4.14.1. Company Overview
    • 8.4.14.2. Financial Performance
    • 8.4.14.3. Product Benchmarking
    • 8.4.14.4. Strategic Initiatives